Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Breast cancer

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Inavolisib with Trastuzumab and Pertuzumab for Patients with HER2-Positive, HR-Positive, PIK3CA Mutant Early Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Inavolisib

Contact Research Centre

Breast cancer

Recruiting

Registered drugNo placebo

Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Breast cancer+3

Recruiting

Registered drug

Study on the Effects of Imipramine in Patients with Colon, Rectal, or Breast Cancer Over-Expressing Fascin1

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Imipramine Hydrochloride

Contact Research Centre

Breast cancer

Recruiting

Registered drugNo placebo

Study on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Breast cancer+38

Recruiting

InvestigationalNo placebo

Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ds-3939A

Contact Research Centre

Breast cancer

Recruiting

Registered drugNo placebo

Study on Indocyanine Green in Axillary Lymph Nodes for Patients with Breast Cancer and Metastatic Lymph Nodes

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Indocyanine Green

Contact Research Centre

Breast cancer+2

Recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Breast cancer

Not yet recruiting

Registered drugNo placebo

Effect of linzagolix and bilastine on breast density in premenopausal women at high risk of breast cancer: a phase II trial

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Bilastine

Contact Research Centre

Breast cancer

Not yet recruiting

InvestigationalNo placebo

ImmunoPET with 89Zr‑trastuzumab to predict response to trastuzumab deruxtecan in patients with locally advanced or metastatic breast cancer

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years

Contact Research Centre

Breast cancer

Not yet recruiting

Registered drugNo placebo

Study of ribociclib with drug combination in early breast cancer patients to test de‑escalated treatment strategies

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Breast cancer+3

Not yet recruiting

Registered drugNo placebo

Effect of a multidisciplinary care pathway on safety of oral anticancer therapy in patients aged ≥70 with cancer (capecitabine and drug combination)

Registered drugNo placebo

France

Participants:65+ years
Substances:Abemaciclib

Contact Research Centre

Breast cancer+2

Not yet recruiting

Registered drug

Efficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Letrozole

Contact Research Centre

Find therapies in clinical trials near you – page 6

168 trials match your criteria

Breast cancer

Study on the Effectiveness of Inavolisib with Trastuzumab and Pertuzumab for Patients with HER2-Positive, HR-Positive, PIK3CA Mutant Early Breast Cancer

Breast cancer

Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

Breast cancer+3

Study on the Effects of Imipramine in Patients with Colon, Rectal, or Breast Cancer Over-Expressing Fascin1

Breast cancer

Study on Post-Neoadjuvant Therapy for Early Breast Cancer Using Ipatasertib, Inavolisib, and Atezolizumab for Patients with High-Risk Early Breast Cancer

Breast cancer+38

Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

Breast cancer

Study on Indocyanine Green in Axillary Lymph Nodes for Patients with Breast Cancer and Metastatic Lymph Nodes

Breast cancer+2

Study Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer

Breast cancer

Effect of linzagolix and bilastine on breast density in premenopausal women at high risk of breast cancer: a phase II trial

Breast cancer

ImmunoPET with 89Zr‑trastuzumab to predict response to trastuzumab deruxtecan in patients with locally advanced or metastatic breast cancer

Breast cancer

Study of ribociclib with drug combination in early breast cancer patients to test de‑escalated treatment strategies

Breast cancer+3

Effect of a multidisciplinary care pathway on safety of oral anticancer therapy in patients aged ≥70 with cancer (capecitabine and drug combination)

Breast cancer+2

Efficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.